https://doi.org/10.4081/hmr.v1i5.249

Molecular pathology of post-transplant lymphoproliferative disorders

Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
Published: May 29, 2009
Abstract Views: 499
Untitled (): 0
PDF: 316
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Daniela Capello
support@pagepress.org
Michaela Cerri
Davide Rossi
Eva Berra
Clara Deambrogi
Silvia Franceschetti
Chiara Vendramin
Lorenzo De Paoli
Valeria Primon
Cecilia Rus
Tamara Destro
Annarita Conconi
Gianluca Gaidano
Posttransplant lymphoproliferative disorders (PTLD) are a major complication of solid organ transplantation and are due to the chronic administration of iatrogenic immunosuppression.1,2 Most PTLD are of B cell origin, frequently involve extra-nodal sites, and display a marked clinical aggressiveness. Despite these common features, PTLD display histological and molecular heterogeneity and may present at different times after transplantation.1-5 Early onset (<1 year after transplantation) PTLD are mainly regarded as Epstein Barr virus (EBV)-driven lymphoproliferations that are frequently, though not always, polyclonal or oligoclonal.1-5 Conversely, most late onset (> 1 year after transplantation) PTLD are true monoclonal lymphoid malignancies that harbor EBV infection only in a fraction of cases.1-5

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Capello, D., Cerri, M., Rossi, D., Berra, E., Deambrogi, C., Franceschetti, S., Vendramin, C., De Paoli, L., Primon, V., Rus, C., Destro, T., Conconi, A., & Gaidano, G. (2009). Molecular pathology of post-transplant lymphoproliferative disorders. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.249
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).